title: Cytolytic hepatitis with a venotonic drug.
authors.forename: C
authors.initials: C
authors.lastname: Sgro
authors.forename: R
authors.initials: R
authors.lastname: Taque
authors.forename: A
authors.initials: A
authors.lastname: Zoll
authors.forename: P
authors.initials: P
authors.lastname: Hillon
mesh_terms: D000328:Adult; D001205:Ascorbic Acid / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology*; D002918:Chymotrypsin; D004338:Drug Combinations; D005260:Female; D005419:Flavonoids / Q000009:adverse effects*; D006569:Hesperidin; D006801:Humans; D007866:Leg / Q000098:blood supply; D010447:Peptide Hydrolases / Q000009:adverse effects*; D010840:Phytosterols / Q000009:adverse effects*; D014357:Trypsin; D014652:Vascular Diseases / Q000188:drug therapy; D014680:Veins
chemical_list: D004338:Drug Combinations; D005419:Flavonoids; D010840:Phytosterols; C021980:hesperidine methylchalcone, ruscus aculeatus, vitamin C; D006569:Hesperidin; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D001205:Ascorbic Acid